Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...

The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

Pfizer has now announced that ... and 100 times The People’s Vaccine Alliance’s estimated cost of manufacture of each vial. This estimation was drawn from an analysis of data from consumer ...

Pfizer's fourth quarter beat expectations on strong sales of its Covid vaccine and pill, bolstering its sales as it seeks to ...

Unexpected demand for Pfizer Inc.’s Covid vaccine helped the company beat quarterly expectations. Then Robert F. Kennedy Jr., ...

In their research, the students used four vials of experimental mRNA vaccines. These vaccines rely on mRNA enclosed in lipid nanoparticles, or tiny bubbles of fat, to deliver instructions to human ...

After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely in the past.”  | The company benefited from higher-than-expected sales of ...